CURRENT PREVENTION STRATEGIES FOR INFLUENZA VIRUS INFECTION: EVIDENCE, PRACTICE, AND THE ROLE OF MATERNAL VACCINATION
DOI:
https://doi.org/10.31435/ijitss.3(47).2025.3976Keywords:
Influenza, Vaccine Effectiveness, Maternal Immunization, Pregnancy, Non-pharmaceutical InterventionsAbstract
Background: Seasonal influenza remains a major cause of morbidity and mortality in Europe. Prevention relies primarily on vaccination, supported by non-pharmaceutical interventions (NPIs) and surveillance. Pregnant women are a key target group, as maternal immunization protects both mother and infant.
Methodology: A narrative review of recent PubMed-indexed studies, complemented by European Centre for Disease Prevention and Control (ECDC) reports and national data from Poland, was undertaken. Evidence on vaccine effectiveness, safety of maternal immunization, vaccination coverage, and the role of NPIs was synthesized.
Results: Influenza vaccine effectiveness in Europe has been moderate, ranging from 32–55% depending on subtype and season, with highest protection against influenza B and lowest against A(H3N2). Maternal vaccination provides significant protection for infants under six months, particularly when administered in the third trimester, and shows no association with adverse pregnancy outcomes. Despite strong evidence, vaccine uptake in Poland remains among the lowest in Europe, with only about 10% coverage in older adults and minimal uptake among pregnant women. NPIs, including mask use and hand hygiene, reduce transmission and are particularly valuable in seasons of poor vaccine match.
Discussion: Vaccination is the cornerstone of influenza prevention, yet insufficient coverage undermines its impact. Maternal immunization remains underutilized, while NPIs provide important complementary protection. Barriers include cost, misinformation, and logistical challenges.
Conclusions: Effective influenza prevention requires higher vaccine uptake, integration of maternal immunization into routine prenatal care, selective use of NPIs, and stronger surveillance. Without systemic improvements, the potential of influenza prevention cannot be fully realized.
References
Maurel, M., Howard, J., Kissling, E., Pozo, F., Pérez-Gimeno, G., Buda, S., Sève, N., McKenna, A., Meijer, A., Rodrigues, A. P., Martínez-Baz, I., Mlinarić, I., Latorre-Margalef, N., Túri, G., Lazăr, M., Mazagatos, C., Echeverria, A., Abela, S., Bourgeois, M., Machado, A., … European IVE group (2024). Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 29(8), 2400089. https://doi.org/10.2807/1560-7917.ES.2024.29.8.2400089
Rose, A. M., Lucaccioni, H., Marsh, K., Kirsebom, F., Whitaker, H., Emborg, H. D., Bolt Botnen, A., O'Doherty, M. G., Pozo, F., Hameed, S. S., Andrews, N., Hamilton, M., Trebbien, R., Lauenborg Møller, K., Marques, D. F., Murphy, S., McQueenie, R., Lopez-Bernal, J., Cottrell, S., Bucholc, M., … Members of the European IVE group (2025). Interim 2024/25 influenza vaccine effectiveness: eight European studies, September 2024 to January 2025. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 30(7), 2500102. https://doi.org/10.2807/1560-7917.ES.2025.30.7.2500102
Maurel, M., Pozo, F., Pérez-Gimeno, G., Buda, S., Sève, N., Oroszi, B., Hooiveld, M., Gomez, V., Domegan, L., Martínez-Baz, I., Ilić, M., Carnahan, A. S., Mihai, M. E., Martínez, A., Goerlitz, L., Enouf, V., Horváth, J. K., Dijkstra, F., Rodrigues, A. P., Bennett, C., … VEBIS study team (2024). Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study. Influenza and other respiratory viruses, 18(1), e13243. https://doi.org/10.1111/irv.13243
Regan, A. K., & Munoz, F. M. (2021). Efficacy and safety of influenza vaccination during pregnancy: Realizing the potential of maternal influenza immunization. Expert Review of Vaccines, 20(6), 649–660. https://doi.org/10.1080/14760584.2021.1915138
Sahni, L. C., Olson, S. M., Halasa, N. B., Stewart, L. S., Michaels, M. G., Williams, J. V., Englund, J. A., Klein, E. J., Staat, M. A., Schlaudecker, E. P., Selvarangan, R., Schuster, J. E., Weinberg, G. A., Szilagyi, P. G., Boom, J. A., Patel, M. M., Muñoz, F. M., & New Vaccine Surveillance Network Collaborators (2024). Maternal Vaccine Effectiveness Against Influenza-Associated Hospitalizations and Emergency Department Visits in Infants. JAMA pediatrics, 178(2), 176–184. https://doi.org/10.1001/jamapediatrics.2023.5639
Vazquez-Pagan, A., Roubidoux, E. K., Cherry, S., Livingston, B., Bub, T., Lazure, L., Sharp, B., Confer, T., Brigleb, P. H., Honce, R., Whitt, K. T., Johnson, M., Meliopoulos, V., & Schultz-Cherry, S. (2023). Maternal immunization with distinct influenza vaccine platforms elicits unique antibody profiles that impact the protection of offspring [Preprint]. bioRxiv. https://doi.org/10.1101/2023.10.30.564827
Wolfe, D. M., Fell, D., Garritty, C., Hamel, C., Butler, C., Hersi, M., Ahmadzai, N., Rice, D. B., Esmaeilisaraji, L., Michaud, A., Soobiah, C., Ghassemi, M., Khan, P. A., Sinilaite, A., Skidmore, B., Tricco, A. C., Moher, D., & Hutton, B. (2023). Safety of influenza vaccination during pregnancy: a systematic review. BMJ open, 13(9), e066182. https://doi.org/10.1136/bmjopen-2022-066182
Getahun, D., Liu, I. A., Sy, L. S., Glanz, J. M., Zerbo, O., Vazquez-Benitez, G., Nelson, J. C., Williams, J. T., Hambidge, S. J., McLean, H. Q., Irving, S. A., Weintraub, E. S., & Qian, L. (2024). Safety of the Seasonal Influenza Vaccine in 2 Successive Pregnancies. JAMA network open, 7(9), e2434857. https://doi.org/10.1001/jamanetworkopen.2024.34857
Properzi, S., Carestia, R., Birettoni, V., Calesso, V., Marinelli, B., Scapicchi, E., Brillo, E., & de Waure, C. (2024). Vaccination of pregnant women: An overview of European policies and strategies to promote it. Frontiers in Public Health, 12, 1455318. https://doi.org/10.3389/fpubh.2024.1455318
Maltezou, H. C., Effraimidou, E., Cassimos, D. C., Medic, S., Topalidou, M., Konstantinidis, T., Theodoridou, M., & Rodolakis, A. (2021). Vaccination programs for pregnant women in Europe. Vaccine, 39(41), 6137–6143. https://doi.org/10.1016/j.vaccine.2021.08.074
Kopciuch, D., Hoffmann, K., Kus, K., Koligat-Seitz, A., Ratajczak, P., Nowakowska, E., & Paczkowska, A. (2024). Analysis of Attitudes and Practices towards the Influenza Vaccine in High-Risk Adults in Poland. Vaccines, 12(3), 341. https://doi.org/10.3390/vaccines12030341
Tang, S., Ji, L., Bishwajit, G., & Guo, S. (2024). Uptake of COVID-19 and influenza vaccines in relation to preexisting chronic conditions in the European countries. BMC geriatrics, 24(1), 56. https://doi.org/10.1186/s12877-023-04623-5
Jagielska, A. M., Jasik, M., & Nitsch-Osuch, A. (2021). Determinants and coverage of seasonal influenza vaccination among women of childbearing age in Poland. Ginekologia polska, 92(1), 35–45. https://doi.org/10.5603/GP.a2020.0138
Wong, J. Y., Lim, W. W., Cheung, J. K., Murphy, C., Shiu, E. Y. C., Xiao, J., Chen, D., Xie, Y., Li, M., Xin, H., Szeto, M., Choi, S., & Cowling, B. J. (2025). Non-pharmaceutical interventions to reduce influenza transmission in households: a systematic review and meta-analysis. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 150, 107291. https://doi.org/10.1016/j.ijid.2024.107291
Fricke, L. M., Glöckner, S., Dreier, M., & Lange, B. (2021). Impact of non-pharmaceutical interventions targeted at COVID-19 pandemic on influenza burden - a systematic review. The Journal of infection, 82(1), 1–35. https://doi.org/10.1016/j.jinf.2020.11.039
Baïssas, T., Boisnard, F., Cuesta Esteve, I., et al. (2021). Vaccination in pregnancy against pertussis and seasonal influenza: Key learnings and components from high-performing vaccine programmes in three countries: The United Kingdom, the United States and Spain. BMC Public Health, 21(1), 2182. https://doi.org/10.1186/s12889-021-12198-2
Downloads
Published
Issue
Section
License
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
How to Cite
